A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Clinical trial NCT02053376 · COMPLETED
Trial details
- NCT number
- NCT02053376
- Sponsor
- Nathan Bahary, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2018-01-07
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.